famotidine has been researched along with Hyperprolactinaemia in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delpre, G | 1 |
| Lapidot, M | 1 |
| Lipchitz, A | 1 |
| Livni, E | 1 |
| Kadish, U | 1 |
1 other study available for famotidine and Hyperprolactinaemia
| Article | Year |
|---|---|
Hyperprolactinaemia during famotidine therapy.
Topics: Aged; Breast; Famotidine; Female; Humans; Hyperprolactinemia | 1993 |